Publications by Hans Olav Melberg
45 publications found
Original articles
Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study
Dig Liver Dis (in press)
DOI 10.1016/j.dld.2024.02.002, PubMed 38433021
Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020
ESC Heart Fail, 10 (1), 405-415
DOI 10.1002/ehf2.14206, PubMed 36266969
Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway
Aliment Pharmacol Ther, 56 (6), 989-1006
DOI 10.1111/apt.17145, PubMed 35902223
A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
BMC Cardiovasc Disord, 22 (1), 88
DOI 10.1186/s12872-022-02522-y, PubMed 35247979
What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
BMJ Open, 11 (9), e050564
DOI 10.1136/bmjopen-2021-050564, PubMed 34580099
First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study
Scand J Gastroenterol, 56 (10), 1163-1168
DOI 10.1080/00365521.2021.1955147, PubMed 34320885
Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study
Therap Adv Gastroenterol, 14, 17562848211021760
DOI 10.1177/17562848211021760, PubMed 34262610
Using fees to reduce bed-blocking: a game between hospitals and long-term care providers
Eur J Health Econ, 22 (6), 931-949
DOI 10.1007/s10198-021-01299-9, PubMed 33895904
Incidence and Prevalence of Inflammatory Bowel Disease in Norway and the Impact of Different Case Definitions: A Nationwide Registry Study
Clin Epidemiol, 13, 287-294
DOI 10.2147/CLEP.S303797, PubMed 33935519
Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016
ESC Heart Fail, 7 (4), 1917-1926
DOI 10.1002/ehf2.12773, PubMed 32530563
Cost-Effectiveness of Noninvasive Screening for Alcohol-Related Liver Fibrosis
Hepatology, 71 (6), 2093-2104
DOI 10.1002/hep.30979, PubMed 31595545
Value in Health: How It Is Defined and Used in Priority Setting and Pricing in Norway
Healthc Pap, 18 (3), 22-28
DOI 10.12927/hcpap.2019.25929, PubMed 31642804
The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
MDM Policy Pract, 4 (1), 2381468318821103
DOI 10.1177/2381468318821103, PubMed 30746499
Cost analysis of mobile radiography services for nursing home residents in Southeast Norway
J Eval Clin Pract, 25 (2), 275-281
DOI 10.1111/jep.13058, PubMed 30362207
Regional differences in anti-TNF-α therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study
Scand J Gastroenterol, 53 (8), 952-957
DOI 10.1080/00365521.2018.1495258, PubMed 30205699
Did adolescents in Norway respond to the elimination of copayments for general practitioner services?
Health Econ, 27 (7), 1120-1130
DOI 10.1002/hec.3660, PubMed 29663571
Did hospitals respond to changes in weights of Diagnosis Related Groups in Norway between 2006 and 2013?
Health Policy, 120 (9), 992-1000
DOI 10.1016/j.healthpol.2016.07.013, PubMed 27567179
Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries
JAMA, 315 (3), 272-83
DOI 10.1001/jama.2015.18603, PubMed 26784775
A new proposal for priority setting in Norway: Open and fair
Health Policy, 120 (3), 246-51
DOI 10.1016/j.healthpol.2016.01.012, PubMed 26851991
European Regional Differences in All-Cause Mortality and Length of Stay for Patients with Hip Fracture
Health Econ, 24 Suppl 2, 53-64
DOI 10.1002/hec.3278, PubMed 26633868
The effects of introducing an electronic prescription system with no copayments
Health Econ Rev, 5 (1), 56
DOI 10.1186/s13561-015-0056-4, PubMed 26174807
Addiction and Responsibility: A Survey of Opinions
Inquiry-Interdiscip. J. Philos., 56 (5), 558-570
DOI 10.1080/0020174X.2013.806143
Norwegian physicians' knowledge of the prices of pharmaceuticals: a survey
PLoS One, 8 (9), e75218
DOI 10.1371/journal.pone.0075218, PubMed 24040402
Addiction: choice or compulsion?
Front Psychiatry, 4, 77
DOI 10.3389/fpsyt.2013.00077, PubMed 23966955
Hospital expenses towards the end of life
Tidsskr Nor Laegeforen, 133 (8), 841-4
DOI 10.4045/tidsskr.12.0802, PubMed 23612105
Measuring the harm of illicit drug use on friends and family
Nord. Stud. Alcohol Drugs, 28 (2), 105-121
Acceptance of unsupported claims about reality: a blind spot in economics
J. Econ. Methodol., 18 (1), 29-52
DOI 10.1080/1350178X.2011.556817
Do smoke-free laws affect revenues in pubs and restaurants?
Eur J Health Econ, 13 (1), 93-9
DOI 10.1007/s10198-010-0287-6, PubMed 21103905
Is cannabis a gateway to hard drugs?
Empir. Econ., 38 (3), 583-603
DOI 10.1007/s00181-009-0280-z
[What do doctors think an MR examination costs?]
Tidsskr Nor Laegeforen, 130 (6), 598-600
DOI 10.4045/tidsskr.08.0071, PubMed 20349003
Sequential patterns of drug use initiation - Can we believe in the gateway theory?
B E J. Econ. Anal. Policy, 8 (2), 1
Becker's rational addiction theory: An empirical test with price elasticities for distilled spirits in Denmark 1911-31
Addiction, 101 (10), 1444-50
DOI 10.1111/j.1360-0443.2006.01551.x, PubMed 16968346
The spread of drug use: epidemic models or social interaction?
Adv Health Econ Health Serv Res, 16, 173-99
PubMed 17867239
Review articles
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
Lancet Gastroenterol Hepatol, 8 (5), 458-492
DOI 10.1016/S2468-1253(23)00003-1, PubMed 36871566
Study-design selection criteria in systematic reviews of effectiveness of health systems interventions and reforms: A meta-review
Health Policy, 104 (3), 206-14
DOI 10.1016/j.healthpol.2011.12.007, PubMed 22325150
Ineligibility and refusal to participate in randomised trials of treatments for drug dependence
Drug Alcohol Rev, 29 (2), 193-201
DOI 10.1111/j.1465-3362.2009.00096.x, PubMed 20447229
Other articles
Useful perspective on an overweight population
Tidsskr Nor Laegeforen, 143 (13)
DOI 10.4045/tidsskr.23.0593, PubMed 37753747
[Payments, principles and priorities]
Tidsskr Nor Laegeforen, 143 (9)
DOI 10.4045/tidsskr.23.0210, PubMed 37341407
Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
Bone Marrow Transplant, 53 (5), 657-660
DOI 10.1038/s41409-018-0091-y, PubMed 29358600
Governance of addictions
Tidsskr. Nor. Laegeforen., 136 (9), 847
Are healthcare expenditures increasing faster for the elderly than the rest of the population?
Expert Rev Pharmacoecon Outcomes Res, 14 (5), 581-3
DOI 10.1586/14737167.2014.919857, PubMed 24831863
[Unnecessary confusion about health expenses]
Tidsskr Nor Laegeforen, 133 (9), 935
DOI 10.4045/tidsskr.13.0506, PubMed 23652135
The economic theory of history: an introduction
Tidsskr. Samfunnsforsk., 54 (3), 396-399
Social cost of alcohol: Not always useless even if subjective?
Nord. Stud. Alcohol Drugs, 29 (4), 355-357
DOI 10.2478/v10199-012-0030-y
Books
Hvilken nytte, for hvem og til hvilken kostnad?: en prospektiv studie av stoffmisbrukere i behandling
In SIRUS-rapport, SIRUS, Oslo, Nr. 4/2003, 166 s.
BIBSYS 040047431, ISBN 82-7171-250-0